Why DBV Technologies Stock Is Soaring Today

Why DBV Technologies Stock Is Soaring Today

Source: 
Motley Fool
snippet: 

DBV Technologies (NASDAQ:DBVT) is a clinical-stage biopharmaceutical company based in France that specializes in developing treatments for food allergies. On Monday, the company announced that the European Medicines Agency (EMA) had validated its Marketing Authorization Application (MAA) for Viaskin, a potential treatment for peanut allergy. As a result of this news, shares of DBV Technologies are skyrocketing today and are up by 43% as of 11:57 a.m. EST, after rising by as much as 82.5% earlier today.